NeuroOne Medical NMTC 深 沪
等待开盘 09-23 09:30:00 美东时间
1.38
+0.080
+6.15%
华盛通- 最 高1.40
- 今 开1.34
- 成交量 10.06万股
- 最 低 1.31
- 昨 收 1.30
- 总市值 1256.60万
- 52周最高 6.96
- 市盈率 静 --
- 换手率 1.10%
- 52周最低 1.30
- 委 比 0.00%
- 总股本 910.58万
- 历史最高 47.82
- 量 比 0.67
- 振 幅 6.92%
- 历史最低 1.31
- 每 手 1
- 风险率 1.25%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多NeuroOne® Expands U.S. Commercialization of FDA-Cleared OneRF® Trigeminal Nerve Ablation System with New Southern California Distribution Agreement
NeuroOne Medical Technologies has signed a new Southern California distribution agreement for its OneRF® Trigeminal Nerve Ablation System, expanding commercial access in key U.S. markets, including the Los Angeles metropolitan area. The system, FDA-cleared for treating trigeminal neuralgia, offers a minimally invasive radiofrequency ablation option. The agreement supports NeuroOne's strategy to build a distribution network across key U.S. markets...
09-17 13:05
NeuroOne Completes Three Large-Animal StereoCED Procedures, Including Combined Drug Delivery And Brain Recording; Builds Momentum Toward Planned Launch Of The StereoCED Platform For Human Investigational Clinical Studies Later This Quarter
Successful Large-Animal Procedures Build Momentum Toward Planned Launch of the StereoCED™ Platform for Human Investigational Clinical Studies Later This Quarter Related StereoCED™ Revenue Expected to be Recognized in the Current Fiscal Quarter EDEN PRAIRIE, Minn. – August 27, 2026 – NeuroOne Med...
08-27 21:08
美股大行评级 | 富国上调闪迪目标价从1400美元升至1550美元；塔吉特、Workday、应用材料等获多家大行上调目标价
今日重点评级关注：富瑞：维持ProMIS Neurosciences"买入"评级，目标价从69美元升至100美元；Benchmark：维持Cineverse"买入"评级，目标价从12美元升至14美元
08-17 13:37
Maxim Group Maintains Buy on NeuroOne Medical Tech, Lowers Price Target to $5
Maxim Group analyst Anthony Vendetti maintains NeuroOne Medical Tech (NASDAQ:NMTC) with a Buy and lowers the price target from $13 to $5.
08-15 04:24
NeuroOne (NMTC) 2026财年第三季度业绩电话会议：订单增长43%，利润率达59.9%
NeuroOne 2026财年第三季度财报电话会议介绍了16%的营收增长、59.9%的毛利率、270万美元的订单，以及受产能限制的业绩指引。
08-14 08:31
NeuroOne Expands At-The-Market Equity Offering Capacity
The latest update is out from NeuroOne Medical Technologies ( ($NMTC) ). On Dec...
06-13 07:36
12 Health Care Stocks Moving In Tuesday's After-Market Session
Gainers Co-Diagnostics (NASDAQ:CODX) shares rose 20.8% to $2.38 during Tuesday...
05-20 05:06
NeuroOne Medical Tech Q2 2026 Earnings Call Transcript
NeuroOne Medical Tech (NASDAQ:NMTC) released second-quarter financial results a...
05-12 23:46
NeuroOne Medical Tech Q2 EPS $(0.25) Misses $(0.23) Estimate, Sales $2.391M Miss $2.576M Estimate
NeuroOne Medical Tech (NASDAQ:NMTC) reported quarterly losses of $(0.25) per share which missed the analyst consensus estimate of $(0.23) by 8.7 percent. This is a 40.48 percent increase over losses of $(0.42) per share
05-12 21:39
